Treatment Course of Recurrent Malignant Glaucoma Monitoring by Ultrasound Biomicroscopy: A Report of Two Cases  by Shen, Chia-Jung et al.
Kaohsiung J Med Sci November 2008 • Vol 24 • No 11608
© 2008 Elsevier. All rights reserved.
Malignant glaucoma is also known as ciliary block
glaucoma or aqueous misdirection glaucoma. It re-
mains one of the most challenging complications
encountered by ophthalmologists. It is described as
occurring most often after simple or combined filtra-
tion procedures in eyes with angle closure glaucoma
[1–3]. However, it can also occur after laser iridotomy
[1,4–6], capsulotomy [7,8], cataract extraction [9],
cyclophotocoagulation [10,11], and initiation caused
by topical miotic therapy [12]. This disease has been
associated with the presence of large optic intraocular
lenses (IOLs) [13] and has even been reported to have
occurred in eyes that have not previously undergone
surgery [1,14].
To study the mechanism underlying malignant
glaucoma and the basis for the clinical classification
of malignant glaucoma, ultrasound biomicroscopy
(UBM) was used in combination with the slit lamp
and axial scan to provide cross-sectional images of the
iris, posterior chamber IOL, and ciliary body, as well
as their relative positions to the malignant glaucoma
[15–17]. Two patients with postoperative malignant
glaucoma were examined by UBM to investigate the
state of the acute stage, the opposite eye, and the state
after the release of the cilio-lenticular block.
CASE PRESENTATIONS
Case 1
An 81-year-old male with no history of glaucoma
underwent uncomplicated extracapsular cataract 
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To study the mechanism underlying malignant glaucoma examined by ultrasound biomicroscopy
(UBM) combined with axial scan and to observe the course of cilio-lens block in living eyes in real
time, when malignant glaucoma occurs and remises, two cases of malignant glaucoma are
reviewed. The two cases have common characteristics, such as short axial length, pseudophakia,
and patent peripheral iridotomy. Both cases eventually achieved intraocular pressure control
without surgical intervention during their management courses. UBM and axial scan were used
for early detection, to confirm the diagnosis of these cases, and to observe the course of treatment.
This method allows patients at risk for the disease to be identified and successfully treated before
irreversible damage to the nerve occurs. These cases accentuate the importance of cycloplegic
drugs in long-term malignant glaucoma treatments.
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extraction with implantation of a PC-IOL in his right
eye at the age of 74, and in his left eye at the age of 76
at the clinic.
Within 1 week postoperatively, the intraocular pres-
sure (IOP) in the left eye increased uncontrollably. He
received several intravenous injections of hyperos-
motic agent (Mannitol) and laser iridotomy to control
the IOP; however, it remained high. He was then
referred to our hospital.
Elevated IOP, shallow anterior chamber and patent
laser peripheral iridotomy (LPI) were noted. Due to
malignant glaucoma being highly suspected, high-
resolution UBM, axial scan, and slit lamp were used
to confirm the diagnosis.
Both the patient’s eyes were small, with an ante-
rior chamber depth/axial length of 3.55/21.50 mm in
the right eye, and 2.18/21.46 mm in the left eye. In
the left eye, the ciliary body rotated anteriorly with 
a narrow angle and patent iridotomy was found on
UBM during the acute stage.
Anterior hyaloidotomy using Nd-YAG laser was
performed and medical treatments for malignant
glaucoma were given to his left eye, consisting of 1%
atropine eyedrops tid, 1% Pred-forte q2h, Rinderon-A
ointment qn, 0.15% Alphagan-P bid, and Diamox
0.5# qid. IOP and anterior chamber depth became
deep 2 days later.
At this point, the patient was lost to follow-up for
a period of 2 months. He later presented with a sensa-
tion of fullness in both eyes and headache (Figure 1).
Recurrent malignant glaucoma of the left eye and
impending malignant glaucoma of the right eye were
suspected; 1% atropine eyedrop qd was given to the
right eye after LPI was performed. Medication for the
left eye was the same as during the first visit. After
medication, his status stabilized again (Figure 2).
Several months later, he suffered from urination
difficulty. Thus, he stopped administering atropine eye-
drops in both eyes by himself for 3 weeks. Elevation
of IOP in the left eye was noted again (Figure 3).
Secondary Nd-YAG anterior hyaloidotomy through
the patent PI was performed (Figure 4), and, under
medication of 1% atropine eyedrops tid, 1% Pred-
forte q1h, Rinderon-A ointment qn, 0.15% Alphagan-P
bid, Diamox 0.5# qid, and oral prednisolone 40 mg
for 3 days, the IOP was well controlled again. Then,
1.5 months later, 1% atropine was tapered to once
daily, 1% Pred-Forte was tapered to q3h, and 0.15%
Alphagan-P continued to be administered twice daily.
The 1% atropine and lower potency topical steroids
were continued for more than 6 months. IOP remained
within normal limits for 5 years.
Case 2
Case 2 was an 88-year-old male with a history of
bilateral angle-closure glaucoma with patent laser 
iridotomy. He had received cataract surgery on his right
eye at the age of 84. The IOP in his right eye was poorly
controlled with four kinds of anti-glaucoma drugs
from his local medical doctor. He was then referred
to our hospital. Trabeculectomy with mitomycin-C








Figure 1. Case 1: pictures of acute attack in both eyes presenting with UBM after being lost to follow-up for 2 months. Forward ciliary
body rotation in both eyes was noted. (A) The right eye’s anterior chamber depth (ACD) was 2.44 mm and the axial length (AXL) 
was 21.38 mm. (B) The left eye’s ACD was 2.29 mm and AXL was 21.49 mm. C= cornea; I= iris plane; B= ciliary body; M=hyaloid
membrane.
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3 months after this operation, high IOP with a flat
anterior chamber in the operated eye was noted. Under
the impression of malignant glaucoma, UBM and tra-
ditional instruments were used to confirm the diag-
nosis. Axial scanning revealed the anterior chamber
depths/axial lengths of both eyes to be 2.01/20.53 mm
(OD) and 2.50/20.86 mm (OS). A change in ciliary
body position in the right eye between the acute 
and resolution stages was clearly observed by UBM
(Figure 5). He was given 1% atropine once daily and
low-dose topical steroids for more than 6 months in
his right eye. No elevation of IOP was ever noted
again (Figure 6).
DISCUSSION
The diagnosis of malignant glaucoma is established
in the presence of a shallow or flat anterior chamber,
a patent iridectomy or iridotomy, and often an ele-
vated IOP in the absence of choroidal effusion or
suprachoroidal hemorrhage. The exact pathophysio-
logic mechanism underlying malignant glaucoma is









Figure 2. Case 1: pictures of remission of both eyes under typical medication, including cycloplegics and topical steroids. (A) Picture
of the right eye without use of antiglaucoma agents; anterior chamber depth was 3.55 mm. (B) Picture of the left eye with two lines 
of antiglaucoma agents being used; anterior chamber depth was 3.22 mm. C= cornea; I= iris plane; B= ciliary body; M=hyaloid 
membrane.
Figure 3. Case 1: recurrent malignant glaucoma attack after





Figure 4. Case 1: UBM shows the left eye in remission with patent
PI and under 1% atropine qd, 1% Pred-Forte q3h, Rinderon-A
ointment qn and 0.15% Alphagan. Arrow indicates patent irido-
tomy and hyaloidotomy. C= cornea; I= iris plane; B= ciliary
body; M=hyaloid membrane.
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be an agreement in the literature regarding the exis-
tence of an abnormal anatomic relationship between
the ciliary processes, the crystalline lens, or IOL and
the anterior vitreous face, which leads to misdirection
of aqueous fluid into the vitreous cavity [16]. This
hypothesis has been supported by findings from
UBM [16,17]. An abnormality in the permeability of
the anterior hyaloid face may also play an important
role in the pathogenesis of this potentially devastating
complication.
Any surgical procedures decompressing the ante-
rior chamber may produce movement of the periph-
eral anterior hyaloid membrane further forward into
apposition with the ciliary body. The usual clinical
situation of malignant glaucoma is that of a postoper-
ative patient followed by filtration, combined cataract/
filtration, or cataract surgery [4–8,11–14]. Malignant
glaucoma develops primarily in eyes with anatomi-
cally narrow anterior chamber angles, especially in
small eyes. Here, the two cases had common charac-
teristics, such as short axial lengths. Both cases were
postoperative patients following filtration or cataract
surgery [1–3], with IOP being eventually well con-
trolled without surgical intervention during the man-
agement course. Malignant glaucoma can occur at any
time during the usual postoperative period of days 
to weeks, months [18], and occasionally even years.
In Case 1, malignant glaucoma of the left eye occurred
within 1 week of cataract surgery, while the right eye
was not affected until more than 2 years later. In 
Case 2, malignant glaucoma occurred 3 months after
trabeculectomy.
There is substantial risk of the recurrence of 
the malignant glaucoma process once cycloplegics
are stopped. Therefore, even with initial success of
mydriatic-cycloplegic therapy, the performance of YAG
hyaloidotomy as an elective procedure should be con-
sidered [18]. Generally, when atropine was contin-
ued, the anterior chamber retained normal depth and
the pressure was lowered. However, when atropine
was discontinued, the chamber became shallow or flat
and pressure rose. In most cases, but not all, this pro-
cess was reversed by reestablishing the use of atropine.
In Case 1, the patient stopped atropine treatment by
himself because of urination difficulty. After discon-
tinuation of atropine for 3 weeks, the malignant glau-
coma returned. The status was reversed after atropine
was re-administered. This demonstrates how side ef-
fects must be considered, because they influence patient
compliance. Topical atropine eyedrops is an anticholin-
ergic agent. Side effects of atropine eyedrops include
micturition difficulties, photophobia, dry mouth and
tachycardia. We can teach patients to compress the
lacrimal sac for 2–3 minutes diligently after adminis-
tration, to lower systemic side effects.
Surgeons should notice the possibility that malig-
nant glaucoma may develop at any time, especially in
small eyes postoperatively. Generally, the axial length
in the Chinese population is shorter than that in the
Western population, and, as a result, malignant glau-
coma occurs more frequently in these smaller eyes
with anatomically narrow anterior chamber angles.
In China, when we face an acute glaucoma attack with




Figure 5. Case 2: UBM picture of acute attack in the right eye.
Anterior chamber depth was 2.01 mm, and axial length was




Figure 6. Case 2: right eye in remission. Anterior chamber depth
was 2.89 mm, and axial length was 20.53 mm. C= cornea; I= iris
plane; B= ciliary body; M=hyaloid membrane.
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or cataract surgery situation, we must pay attention
to the possibility of malignant glaucoma.
We made use of UBM combined with axial scan
and slit lamp to provide images consistent with
accepted concepts of the pathophysiology of malig-
nant glaucoma, which helped us to make an accurate
diagnosis. These procedures will allow individuals at
risk for the disease to be identified and successfully
treated before irreversible damage to the optic nerve
has occurred. These two cases show the importance
of using cycloplegic drugs to treat malignant glau-
coma for the long-term.
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反覆發作之惡性青光眼，以超音波生物診斷儀追蹤
其治療過程 — 二病例報告
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藉由超音波生物診斷儀合併眼部軸性超音波，來確立診斷及觀察惡性青光眼之表現及
治療成效。我們觀察兩位病患，共三隻眼睛發生惡性青光眼的案例。觀察其共同之臨
床表現及治療經過，並比較其相同性及差異性。藉由超音波生物診斷儀，讓我們更容
易觀察惡性青光眼的臨床表現及治療成效，並確立診斷，以防不可逆的視神經病變傷
害發生。經臨床案例表現，來強化睫狀肌麻痺劑對惡性青光眼，長期治療之重要性。
關鍵詞：眼內房水逆流症，惡性青光眼，超音波生物診斷儀
(高雄醫誌 2008;24:608–13)
